Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
BMC Medical Research Methodology|April 6, 2010
The Jamaica asthma and allergies national prevalence survey: rationale and methodsEulalia K Kahwa, Novie O Younger, Yvonne B Wint, et al.
Peerj|February 20, 2018
Factors associated with elevated blood pressure or hypertension in Afro-Caribbean youth: a cross-sectional studyTrevor S Ferguson, Novie O M Younger-Coleman, Marshall K Tulloch-Reid, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 16, 2016
Pretransplantation Exercise and Hematopoietic Cell Transplantation Survival: A Secondary Analysis of Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0902)John R Wingard, William A Wood, Michael Martens, et al.
Plos One|June 11, 2014
Peri-transplant psychosocial factors and neutrophil recovery following hematopoietic stem cell transplantationJennifer M Knight, Jan A Moynihan, Jeffrey M Lyness, et al.
The Yale Journal of Biology and Medicine|April 4, 2022
Rap1A, Rap1B, and β-Adrenergic Signaling in Autologous HCT: A Randomized Controlled Trial of PropranololAlexander K Johnson, Ellen L Lorimer, Aniko Szabo, et al.
Frontiers in Immunology|July 22, 2022
Biobehavioral Implications of Covid-19 for Transplantation and Cellular Therapy RecipientsJennifer M Knight, Mallory R Taylor, Kelly E Rentscher, et al.
Blood Advances|February 7, 2020
Propranolol inhibits molecular risk markers in HCT recipients: a phase 2 randomized controlled biomarker trialJennifer M Knight, J Douglas Rizzo, Parameswaran Hari, et al.
JMIR Research Protocols|September 14, 2016
EXpanding Treatment for Existing Neurological Disease (EXTEND): An Open-Label Phase II Clinical Trial of Hydroxyurea Treatment in Sickle Cell AnemiaAngela E Rankine-Mullings, Courtney R Little, Marvin E Reid, et al.
Communications Medicine|May 23, 2022
Patient-reported outcomes and neurotoxicity markers in patients treated with bispecific LV20.19 CAR T cell therapyJennifer M Knight, Aniko Szabo, Igli Arapi, et al.
Translational Psychiatry|January 19, 2021
The IL-6 antagonist tocilizumab is associated with worse depression and related symptoms in the medically illJennifer M Knight, Erin S Costanzo, Suraj Singh, et al.
Pageof 11